April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Tak1 Interactions With TRPV1 and CB1 Control IL-6 and IL-8 Release in Human Corneal Epithelial Cells
Author Affiliations & Notes
  • Zheng Wang
    Biological Sciences, SUNY College of Optometry, New York, New York
  • Hua Yang
    Biological Sciences, SUNY College of Optometry, New York, New York
  • Jose E. Capo-Aponte
    Visual Sciences Branch, US Army Aeromedical Rsrch Lab, Fort Rucker, Alabama
  • Nili Parekh
    Biological Sciences, SUNY College of Optometry, New York, New York
  • Peter S. Reinach
    Biological Sciences, SUNY College of Optometry, New York, New York
  • Footnotes
    Commercial Relationships  Zheng Wang, None; Hua Yang, None; Jose E. Capo-Aponte, None; Nili Parekh, None; Peter S. Reinach, None
  • Footnotes
    Support  EY04795 and W81XWH-09-2-0162
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 416. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Zheng Wang, Hua Yang, Jose E. Capo-Aponte, Nili Parekh, Peter S. Reinach; Tak1 Interactions With TRPV1 and CB1 Control IL-6 and IL-8 Release in Human Corneal Epithelial Cells. Invest. Ophthalmol. Vis. Sci. 2011;52(14):416.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Corneal epithelial injury-induced transient receptor potential vanilloid 1 (TRPV1) channel activation provokes inflammation through increases in IL-6 and IL-8 release whereas costimulation of the cannabinoid receptor subtype 1 (CB1) blunts this response. We determined in SV40-immortalized human corneal epithelial cells (HCEC) if the opposing effects elicited by TRPV1 and CB1 activation on IL-6 and IL-8 release are elicited through differential modulation of JNK1/2 and NF-ΚB activation through changes in transforming growth factor-β-activated kinase 1 (TAK1) phosphorylation.

Methods: : HCEC lysates were coimmunoprecipated with either anti TRPV1, TAK1, CB1 or TAB1 antibodies followed by Western blotting with an appropriate antibody to probe for protein-protein interactions. Changes in I-ΚB phosphorylation status provided readout of NF-ΚB activation. ELISA determined the individual effects of TRPV1 and CB1 activation as well as TAK1 inhibition on IL-6 and IL-8 release.

Results: : Ten µM capsaicin or 5 µM WIN55,212-2 induced transient activation through interactions between TRPV1 and CB1. These receptors also had the same effects on TAK1 as well as its associated partner, TAB1. TRPV1 and CB1-induced TAK1 phosphorylation (i.e. activation) was larger and invariant during exposure to 1 µM okadaic acid. Capsaicin induced larger increases in TAK1 phosphorylation than those caused by 10 µM WIN55,212-2. These effects were eliminated by either 5 µM capsazepine or AM251, respectively. Receptor-induced TAK1, JNK1/2, I-ΚB phosphorylation and increases in IL-6 and IL-8 release were fully blocked by a selective TAK1 inhibitor, 10 nM (5Z)-7-oxozeaenol.

Conclusions: : Capsaicin-induced TAK1-TAB1 complexation mediates IL-6 and IL-8 increases through JNK1/2 and NF-ΚB phosphorylation. Differences in the magnitude of TAK1 activation induced by either TRPV1 or CB1 stimulation may help explain why only capsaicin induced rises in IL-6 and IL-8 release. TAK1 may be a drug target to reduce injury-induced corneal inflammation without compromising TRPV1-induced increases in corneal wound healing.

Keywords: cornea: epithelium • inflammation • signal transduction: pharmacology/physiology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×